Skip to main content

Will Gibbs

Partner, Octopus Ventures

Will joined Octopus in 2013 and sits on the Health team. He works with portfolio companies from consumer to enterprise, with a strong bias towards businesses making the biggest impacts on health.

In recent years he has explored taboo areas within health, resulting in multiple new investments around this theme, from substance addiction to LGBT sexual health. He’s also passionate about the potential for digital therapeutics to deliver superior outcomes for some conditions, US expansion, the future of cannabinoids and novel business models within health.

Will was based in our US office in New York during 2016, and continues to support portfolio companies looking to expand into the US health market. Many of his portfolio companies are based in the US, and he invests alongside big global investors like SoftBank Group, Kinnevik, Atomico and EQT Partners.

Will is also a vocal champion of diversity and LGBT issues and is happily married to his husband Christopher.

He founded multiple startups before joining Octopus Ventures, including a rare-breed pig farm and an organic spirits company.

Will holds a degree in ancient history and classical archaeology from the University of Oxford.

Octopus Ventures
Panel: 10:25 – 11:20

Leveraging the power of technology to disrupt health care

This panel will explore emerging areas of health tech that offer some of the biggest opportunities for investors. From what exciting technologies are converging to what new innovations have the potential to disrupt the UK health care industry, this panel will delve into everything from what challenges the sector faces, future predictions for the sector, where they’re investing and more.